Iagaru, A., Cardaci, G., Hansen, A. R., Wong, J. Y., Artigas, C., Goffin, K., Villanueva-Vázquez, R., Castellano, D., Mottaghy, F., Robert, A., Zhao, J., Zhang, J., Heeger, S., Schumacher, K., Herrmann, K. (2025). A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5117